Black Diamond Therapeutics, Inc. (BDTX)
$2.23-$0.04 (-1.76%) Today
Latest BDTX Insider Trades
Ali BehbahaniGrant or award40,000 sh
Ali Behbahani
Kapil DhingraAli BehbahaniBlack Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.
https://www.blackdiamondtherapeutics.comSEC filings for BDTX on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 8 | 256,868 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
20 Form 4 filings on record, the earliest from Dec 16, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ali Behbahani | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
 Samarth Kulkarni | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Garry E. Menzel | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Prakash Raman | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Kapil Dhingra | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Shannon Campbell | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Ali Behbahani | Grant or award | Common Stock | 8,961 | $1.66 | $15K | |
| Prakash Raman | Grant or award | Common Stock | 7,907 | $1.66 | $13K | |
| Ali Behbahani | Grant or award | Common Stock | 6,919 | $2.15 | $15K | |
| Prakash Raman | Grant or award | Common Stock | 6,105 | $2.15 | $13K | |
| Erika Jones - Officer | Grant or award | Stock Option (Right to Buy) | 200,000 | $0.00 | - | |
 Brent Hatzis-Schoch - Officer | Grant or award | Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
 Elizabeth Buck - Officer | Grant or award | Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
 Sergey Yurasov - Officer | Grant or award | Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
 Mark A. Velleca - Officer | Grant or award | Stock Option (Right to Buy) | 600,000 | $0.00 | - | |
| Prakash Raman | Grant or award | Common Stock | 3,843 | $3.35 | $13K | |
| Ali Behbahani | Grant or award | Common Stock | 4,291 | $3.35 | $14K | |
| Prakash Raman | Grant or award | Common Stock | 5,150 | $2.50 | $13K | |
| Shannon Campbell | Grant or award | Common Stock | 4,500 | $2.50 | $11K | |
| Ali Behbahani | Grant or award | Common Stock | 5,750 | $2.50 | $14K |
Black Diamond Therapeutics, Inc. (BDTX) had 8 insider filings in the last 90 days, with the most recent on 2026-06-29. The full record for BDTX runs to 20 Form 4 filings, the earliest from 2024-12-16. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of BDTX were filed in the last 90 days.
No insider sales of BDTX were filed in the last 90 days.
This page tracks BDTX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add BDTX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
